Quantum-Synaptic Immunotherapy Mapping Using Low-Frequency Electromagnetic Resonance and Machine Learning-Based Cytokine Forecasting

NCT07221565 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ENROLLING_BY_INVITATION

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus
Rheumatoid Arthritis
Multiple Sclerosis
Autoimmune Diseases
Chronic Inflammatory Syndromes
Immune Dysregulation

Interventions

DEVICE: Low-Frequency Electromagnetic Resonance Therapy (LF-EMR)
DEVICE: Sham Resonance Device (Inactive Control)
DRUG: Low-Dose Naltrexone (LDN)

Sponsor

Truway Health, Inc.